Selected new antithrombotic agents and neuraxial anaesthesia for major orthopaedic surgery: management strategies.
about
Neuraxial and peripheral nerve blocks in patients taking anticoagulant or thromboprophylactic drugs: challenges and solutionsClopidogrel and hip fractures, is it safe? A systematic review and meta-analysisPerioperative management of patients on direct oral anticoagulants.Preventive strategies against bleeding due to nonvitamin K antagonist oral anticoagulants.Incidence of neuraxial haematoma after total hip or knee surgery: RECORD programme (rivaroxaban vs. enoxaparin).Dabigatran for stroke prevention in nonvalvular atrial fibrillation: answers to challenging "real-world" questions.Type of anaesthesia and the safety and efficacy of thromboprophylaxis with enoxaparin or dabigatran etexilate in major orthopaedic surgery: pooled analysis of three randomized controlled trials.Practical management of new oral anticoagulants after total hip or total knee arthroplasty.The ''critical thrombosis period'' in major orthopedic surgery: when to start and when to stop prophylaxis.New anticoagulants: how to deal with treatment failure and bleeding complications.Dabigatran etexilate in clinical practice: confronting challenges to improve safety and effectiveness.Clinical management of rivaroxaban-treated patients.Rivaroxaban in the treatment of venous thromboembolism and the prevention of recurrences: a practical approach.The effects of timing of prophylaxis, type of anesthesia, and use of mechanical methods on outcome in major orthopedic surgery - subgroup analyses from 17,701 patients in the XAMOS study.Emerging antithrombotic agents for thromboprophylaxis, clinical potential and patient considerationsPoor prognosis after surgery for intertrochanteric fracture in elderly patients with clopidogrel treatment: A cohort studyWithholding clopidogrel for 3 to 6 versus 7 days or more before surgery in hip fracture patients.New anticoagulants: perioperative considerations.
P2860
Q26782931-2F6B11B7-2F73-4AEB-8257-16F371533B67Q28068229-03715900-F0D8-4170-99BB-F7B842C18B69Q33692054-45EDBC37-D054-453D-9667-76E501BEE72DQ33854667-DA5443A7-DE02-473B-A510-99C5F1F1B450Q34035190-71298182-9E3F-40C7-8288-A763B56705AAQ35975334-6DE37AC4-7C78-49EC-A6BF-FA94A41F4CD4Q36240036-00079E31-155E-486A-9C9E-A359233D1925Q37338120-A2B56B07-9269-4058-814B-8871BCFC10AFQ37657993-5C540BA9-55DB-4D61-A46F-71CCAE759C35Q37900670-0B0EB72F-B039-480B-B9D0-597865A09ABEQ37961830-46439742-C5FE-4327-95F4-9B047B4F9288Q38081946-A795E6C6-E913-4E83-B232-4723F74B2C54Q38287849-F6B0446B-8FA3-4C18-8F4C-B59E9C556F2AQ39701887-84C5EB57-4022-40BF-9CEA-D35AD8DEBF7CQ40539614-B79514ED-F056-4E75-8F07-963F00CCEDD3Q42283336-7596F1D9-2D3B-4711-A2D2-21E5597C2446Q44787178-E8359E09-A137-4E64-9DB7-23306AF4BBB1Q48279016-C844D3A8-1112-4D4D-BB4C-2A761C206B30
P2860
Selected new antithrombotic agents and neuraxial anaesthesia for major orthopaedic surgery: management strategies.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Selected new antithrombotic ag ...... urgery: management strategies.
@en
type
label
Selected new antithrombotic ag ...... urgery: management strategies.
@en
prefLabel
Selected new antithrombotic ag ...... urgery: management strategies.
@en
P1433
P1476
Selected new antithrombotic ag ...... urgery: management strategies.
@en
P2093
Rosencher N
P2860
P304
P356
10.1111/J.1365-2044.2007.05195.X
P407
P577
2007-11-01T00:00:00Z